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potencial de membrana
resumo As estirpes eméticas de Bacillus cereus produzem uma toxina altamente 
resistente, denominada cereulida. Esta toxina é o agente responsável por 
uma intoxicação alimentar caracterizada por emese. A cereulida é um 
dodecadepsipéptido cíclico com uma estrutura semelhante à da valinomicina, 
um composto antimicrobiano produzido por Streptomyces spp. Ambos os 
compostos são ionóforos de potássio, facilitando o movimento the K+ através 
das membranas celulares com concomitante dissipação do potencial de 
membrana. Devido às suas propriedades ionofóricas, a valinomicina e a 
cereulida são ambas tóxicas para as mitocôndrias.  As similaridades com a 
valinomicina sugerem que a cereulida possa ser um composto 
antimicrobiano. A actividade antimicrobiana da cereulida e da valinomicina foi 
testada avaliando o seu efeito no crescimento das bactérias seleccionadas 
sob diferentes condições de crescimento. A valinomicina e a cereulida 
exibiram actividade antimicrobiana contra as bactérias Gram positvo testadas. 
Por outro lado, as bactérias Gram negativo revelaram-se insensíveis a estes 
ionóforos de potássio sob as condições testadas. À excepção de 
Enterococcus faecalis, o crescimento bacteriano foi fortemente inibido pela 
valinomicina e pela cereulida a pH 8.5. Enquanto que a pH 6.5 estes 
ionóforos foram ineficazes. O oxigénio revelou-se um importante factor para a 
eficiência dos ionóforos. As células aeróbicas foram mais sensíveis à acção 
da valinomicina e da cereulida do que as células anaeróbicas. As estirpes 
eméticas revelaram uma menor suscepibilidade aos ionóforos testados. 
Curiosamente, a estirpe não emética Bacillus cereus ATCC 14579 mostrou, 
ao contrário das outras estirpes não eméticas, alguma resistência à 
valinomicina.
keywords Cereulide, valinomycin, potassium ionophores, antimicrobial activity, 
membrane  potential
abstract Emetic Bacillus cereus produce an highly resistant toxin, named cereulide. 
This toxin is the causative agent of a food-borne disease characterized by 
emesis. Cereulide is a cyclic dodecadepsipeptide with a structure similar to 
the one of valinomycin, an antimicrobial compound produced by 
Streptomyces spp. Both of these compounds are potassium ionophores, 
facilitating the movement of K+ across cell membranes with concomitant 
dissipation of the membrane potential.  Due to their ionophoric properties, 
valinomycin and cereulide are both toxic to mitochondria. The similarities with 
valinomycin suggest that cereulide may be an antimicrobial compound. The 
antimicrobial activity of cereulide and valinomycin was evaluated in relation to 
growth of selected bacteria under different growth conditions. Valinomycin and 
cereulide were found to exhibit antimicrobial activity effective against the 
Gram positive bacteria tested. Gram negative were insensitive to these 
potassium ionophores in the conditions used. With the exception of 
Enterococcus faecalis, bacterial growth was strongly inhibited by valinomycin 
and cereulide at pH 8.5. While at pH 6.5 these potassium ionophores were 
inefective. Oxygen was found to be an important effector of ionophore 
efficiency. Aerobic cells were more sensitive to valinomycin and cereulide than 
anaerobic cells. The emetic Bacillus strains were found to be less susceptible 
to the tested ionophores. Interestingly, the non-emetic Bacillus cereus ATCC 
14579 showed, unlike the other tested non-emetic strains, some resistance to 
valinomycin.
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1. INTRODUCTION
1.1.  Microbial warfare
The availability of nutrients and space is limited, which leads to competition between 
microorganisms.  To gain the competition,  microorganisms developed several  strategies. 
One of those strategies is the synthesis of antibiotics, which are compounds that can inhibit 
the  growth  or  even  kill  other  microorganisms.  Antibiotics  can  be  specific  for  some 
microorganisms or have a broad-spectrum,  according to their mode of action (Riley and 
Wertz, 2002). These compounds are usually synthesized during post-logarithmic growth 
after exhaustion of nutrients and space for bacterial multiplication (Martin and Demain, 
1980). 
1.2.  Cell metabolism and energetics
Movement  of  anions,  nutrients  and  metabolites  across  cytoplasmic membranes  is 
mediated by a proton motive force, originated from the electrochemical gradient of protons 
(Mitchell,  1966;  Gale,  1971;  Harold,  1972).  According  to  the  chemiosmotic  theory of 
Mitchell (Mitchell, 1966), the proton motive force is composed of a transmembrane pH 
gradient (alkaline inside) and of a transmembrane electrical potential (negative inside). On 
respiring  and fermentative  bacteria  the  proton  motive  force  is  established  by different 
mechanisms, schematized in Figure 1. Bacterial respiration conducts through the extrusion 
of  protons,  which  creates  an  imbalance  and  charge  difference  between  the  intra  and 
extracellular milieu - proton motive force (Kashket, 1981). Due to the proton-motive force, 
protons return to  the cytoplasm by passing through an ATPase in  the membrane,  with 
concomitant generation of ATP. In fermentative bacteria, ATP is produced by substrate-
level  phosphorylation  (Nakano  and  Zuber,  1998).  Thus,  the  proton  motive  force  is 
generated  by  the  extrusion  of  protons  through  ATPase,  during  the  hydrolysis  of  ATP 
(Harold, 1972; Kashket, 1981).
There  are  many  factors  that  can  interfere  with  the  pH  gradient  and  with  the 
membrane potential across membranes. The metabolic processes associated with growth 
and metabolism are the main cause of perturbation of the pH gradient across the membrane 
(Booth, 1985). While the membrane potential is, essentially, disturbed by compounds such 
as antibiotics that disturb the balance of ions in the cell. A decrease or even the collapse of 
1
the proton motive force can be fatal for cells. Therefore, bacteria usually can compensate 
the dissipation of one of the components of the proton motive force with the increase of the 
other component (Abee et al., 1988).
Figure 1. Schematic representation of cellular mechanisms involved in the generation of a proton motive 
force in respiring and fermentative bacteria. The driving force is generated by extrusion of protons by the 
respiratory chain (respiring bacteria) or by the ATPase (fermentative bacteria).  Adapted from Harold, 1974.
1.3.  Valinomycin
Valinomycin  is  a  well  known  antibiotic  produced  by  species  of  the  genus 
Streptomyces  (Mikkola  et  al.,  1999,  Magarvey  et  al.,  2006),  which  is  a  cyclic 
dodecadepsipeptide  containing  the  three-repeat  sequence  D-hydroxyisovaleric  acid-D-
valine-L-lactic  acid-L-valine  (Pressman,  1965;  Magarvey  et  al.,  2006),  of  molecular 
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weight 1111.3218 (http://www.ncbi.nlm.nih.gov/). This peptide forms a central hydrophilic 
cavity in which a monovalent cation, generally a potassium ion, can be accommodated 
(Daniele and  Holian, 1976). Coating this polar cage, valinomycin has hydrophobic side 
chains of valine and hydroxyisovaleric acid, (Figure 2) which allow its diffusion through 
the  hydrophobic  interior  of  cell  membranes  (Lehninger  et  al.,  1993).  Valinomycin  is 
classified as a potassium ionophore (Lehninger  et al., 1993) which means that when the 
K+-valinomycin  complex  is  formed,  as  the  charge  of  the  potassium  ion  is  shielded 
(Morrison et al., 2005), the K+ is carried by valinomycin across the hydrophobic interior of 
cell membranes down its electrochemical gradient (Lehninger et al., 1993; Morrison et al., 
2005).  The  transport  of  K+ by  valinomycin  across  cell  membranes  dissipates  the 
transmembrane  electrical  potential  (Muchl  and  Peschek,  1984)  and  consequently,  the 
proton motive force. 
Figure 2. Valinomycin structure. The central hydrophilic cavity is formed by the oxygen atoms (red) that 
bind K+ (atom in the center). Coating this cavity, there are the hydrophobic side chains (yellow). 
Lehninger et al., 1993.
1.4.  Bacillus cereus and cereulide
Bacillus cereus is a Gram positive, facultative anaerobic, spore-forming, motile and 
an ubiquitously present rod (Kotiranka et al., 2000), which belongs to the B. cereus group, 
also  known  as  B.  cereus  sensu  lato.  This  group  comprises  the  species  B.  cereus,  B. 
weihenstephanensis,  B. mycoides, B. pseudomycoides, B. anthracis  and B. thuringiensis  
(Kotiranka et al., 2000,  Ehling-Schulz et al., 2004, Arnesen et al., 2008). Bacillus cereus 
is found in bulk soil, in the rhizosphere (Vilain et al., 2000), in the air (Arnesen  et al., 
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2008), in the gut of invertebrates (Jensen  et al., 2003) and is commonly present in food 
(Granum et al., 1997, Ehling-Schulz et al., 2004).
There are two distinct  food-borne disease types associated with  B. cereus named 
diarrheal and emetic syndromes. The diarrheal syndrome is caused by enterotoxins that are 
produced during the growth of vegetative cells in the small intestine, after the ingestion of 
contaminated  food  (Adams  and Moss,  2008).  The  emetic  syndrome is  an  intoxication 
caused by cereulide, a toxin produced in food by emetic  B. cereus (Granum et al., 1997, 
Arnesen  et al., 2008) and by the psychrotolerant  B. weihenstephanensis  (Thorsen  et al., 
2006). The two types of food-borne illness are connected to different types of food. While 
meat products, soups, vegetables, puddings and sauces are often implicated in the diarrheal 
syndrome (Adams and Moss, 2008), the emetic syndrome is commonly associated with 
starchy products such as rice, pasta (Agata et al., 2002; Adams and Moss, 2008), noodles, 
pastry  (Ehling-Schulz  et  al.,  2004)  and  potatoes  (Agata  et  al.,  2002;  Altayar  and 
Sutherland, 2006) in spite of the inability of emetic B. cereus to hydrolyze starch (Ehling-
Schulz et al., 2004).
The emetic toxin is produced by emetic strains in the beginning of their stationary 
phase (Finlay et al., 2000; Thorsen et al., 2009), at temperatures ranging from 12 to 37°C 
(Finlay  et  al.,  2000),  with  the  exception  of  the  psychrotrophic  B.  weihenstephanensis 
which is  able  to  produce  cereulide  at  8°C (Thorsen  et  al.,  2006).  Cereulide  is  a  very 
resistant toxin, maintaining its stability at temperatures up to 121°C, extreme pH and being 
also resistant to proteolysis (Granum et al., 1997; Kotiranta  et al., 2000; Arnesen  et al., 
2008). Therefore, cereulide can be a serious problem concerning food safety.
Cereulide,  represented on  Figure 3,  has  been shown to cause emesis  in  primates 
(Agata et al., 1995) and mice (Turnbull  et al., 1979), swelling of mitochondria in HEP-2 
cells (Agata et al., 1994), in boar spermatozoa (Andersson et al., 1998) and in natural killer 
cells of the immune system (Paananen et al., 2002). The toxic effect of cereulide was also 
described for hepatocytes after two cases of lethal food poisoning by this toxin (Mahler et  
al., 1997; Dierick et al., 2005)
The function of cereulide in B. cereus growth and ecology is unknown. It is known 
that cereulide causes emesis (Arnesen et al., 2008) but it has no apparent benefit for emetic 
B. cereus. Synthesis of secondary metabolites have a cost for cells (Kell et al., 1995), thus 
it must be profitable for their producers. The toxic effect of cereulide in mammalian cells is 
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most likely just a collateral effect and not its main function. 
The  synthesis  of  cereulide  occurs  during  the  same  growth  phase  as  sporulation 
(Finlay et al., 2000; Häggblom et al., 2002), the absence of both events under anaerobiosis 
(Jääskeläinen et al., 2004), the association between the main regulator for sporulation with 
cereulide synthesis (Lücking  et al., 2009) and the association of enterotoxin production 
with  sporulation  in  other  microorganisms  (Duncan  et  al.,  1972)  seems  to  indicate  a 
correlation between synthesis of cereulide and sporulation. However there is no evidence 
of this association. There is no relation between the amount of spores and the amount of 
cereulide produced (Finlay et al., 2000; Häggblom et al., 2002). The emetic strains are able 
to sporulate even without the production of cereulide (Finlay  et al., 2000). Furthermore, 
the sporulation sigma factor H (σH)  which plays an important role in post-exponential-
phase  gene  expression,  showed  no  relation  with  cereulide  expression  (Lücking  et  al., 
2009).
Figure 3. Schematic representation of cereulide.
Several factors indicate the possibility of cereulide being an antimicrobial compound. 
Valinomycin and cereulide have similar structures (Agata  et al., 1994), differing only in 
two  of  the  four  residues  that  form  the  three-repeat  sequence.  Both  compounds  are 
potassium ionophores (Mikkola et al., 1999) carrying potassium ions across the membrane 
down  an  electrochemical  gradient.  Moreover,  these  potassium ionophores  both  inhibit 
mitochondrial  activity by dissipation of the membrane potential  (Mikkola  et al.,  1999). 
Most  likely,  they also have  the  same function  playing  a  role  in  microbial  warfare  for 
nutrients. As observed with the majority of the antibiotics,  synthesis of cereulide starts 
during the stationary phase (Finlay  et al., 2000; Thorsen  et al., 2009). Its production is 
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enhanced at 20°C (Finlay et al., 2000) and is oxygen dependent (Jääskeläinen et al., 2004) 
suggesting that it  is not an human pathogenic agent.  Cereulide may be targeted against 
bacteria,  but  due  to  biochemical  similarities  between  bacterial  cells  and  mitochondria, 
these are also affected by this ionophore.
1.5.  Objectives
The  toxic  character,  the  high  stability  and  the  optimal  synthesis  conditions  of 
cereulide are known, but the main question, “why is cereulide produced?”, still does not 
have an answer. The present study tried to give an answer to that question. 
As mentioned above, there are several factors pointing to the fact that cereulide may 
be an antimicrobial compound. Therefore, the goal of this study was to test if cereulide 
could be or not an antimicrobial compound.
Since  cereulide  is  similar  to  valinomycin,  which  is  already  an  well  studied 
compound,  both  compounds  were  studied  in  parallel  in  order  to  better  evaluate  the 
antimicrobial activity of cereulide.
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2. MATERIALS AND METHODS
2.1.  Bacterial strains and culture conditions
The antimicrobial activity of valinomycin and cereulide was tested on selected Gram 
positive and Gram negative bacteria which are shown in Table 1.
Stock cultures grown in Brain Heart Infusion broth (BHI, Becton Dickinson, France) 
were stored at -80°C in ~26 % v/v of glycerol.
Table 1. Bacterial strains and their characteristics.
Microorganisms Gram Oxygen Requirement Observations
Escherichia coli ECO 016 - Facultative anaerobic 
Salmonella thyphimurium II 505 - Facultative anaerobic
Enterococcus faecalis ATCC 29212 + Microaerophilic without functional electron transport chain
Staphylococcus aureus ATCC 25923 + Facultative anaerobic
Listeria  innocua + Facultative anaerobic
Listeria monocytogenes + Facultative anaerobic 
Bacillus subtilis 168 + Facultative anaerobic
Bacillus cereus ATCC 10987 + Facultative anaerobic non-emetic strain(cereulide non-producer)
Bacillus cereus ATCC 14579 + Facultative anaerobic non-emetic strain(cereulide non-producer)
Bacillus cereus F4810/72 + Facultative anaerobic emetic strain (cereulide producer)
Bacillus cereus A529 + Facultative anaerobic emetic strain(cereulide producer)
Stock cultures were streaked on BHI agar plates and incubated overnight at 30°C. A 
single colony was used to inoculate 6 or 8 ml of BHI broth in tubes, which were grown at 
30°C at 200 rpm (Innova 4335; New Brunswick Scientific, The Netherlands) for 17 to 27h. 
The cultures of  B. cereus  ATCC 14579,  B. cereus 10987 and  B. cereus  F4810/72 
used for the survival and recovery assay were prepared by inoculating a single colony in 20 
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ml of BHI broth in a 100 ml Erlenmeyer flask, followed by 14 to 17 hours of growth in a 
shaking water bath (Julabo SW23) at 30°C and 200 rpm.
2.2.  Preparation of valinomycin and cereulide solutions
Stock  solutions  of  valinomycin  were  prepared  using  valinomycin  ready  made 
solution in DMSO (Sigma-Aldrich, 1 mg/ml) and valinomycin powder (Sigma-Aldrich) 
according to the description in Table 2.
Synthetic cereulide, stored in methanol at -20°C, after evaporation of methanol by air 
drying,  was  used  to  prepare  four  different  stock solutions.  Cereulide  was  dissolved  in 
DMSO and dilutions were made with H2O as described in Table 3.
All stock solutions were stored at 4°C. 
Table 2. Preparation of stock solutions of valinomycin and their concentrations.
Final concentration Stock solution
Valinomycin 
(μM)
DMSO
(%)
Concentration
of valinomycin 
(μM)
Concentration 
of DMSO
(%)
Preparation
0.09 1 1.80 20 ss (89.98 μM) + 20 % DMSO (1:9)
0.90 1 18.00 20 ss (179.97 μM) + 20 % DMSO (1:9)
4.50 1 89.98 20 ss (179.97 μM) + 20 % DMSO (1:1)
9.00 1 179.97 20 rms + H2O (1:4)
22.50 5 449.92 100 rms + 100 % DMSO (1:1)
44.99 5 899.83 100 rms
n.d. n.d. 9.00 1 rms + H2O (1:99)
n.d. n.d. 179.97 4 vp + 4 % DMSO 
n.d. n.d. 899.83 4 vp + 4 % DMSO
n.d.: not determined
ss: stock solution
rms: ready made solution of valinomycin in DMSO
vp: valinomycin powder
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Table 3. Preparation of stock solutions of cereulide and their concentrations.
Final concentration Stock solution
Cereulide 
(μM)
DMSO
 (%)
Concentration 
of cereulide 
(μM)
Concentration of 
DMSO 
(%)
Preparation
8.39 1 167.84 20 cereulide dissolved in 100 % 
DMSO + H2O (1:4)
8.39 1 839.18 100 cereulide dissolved in 100 % 
DMSO
9.00 1 179.97 20 cereulide dissolved in 100 % 
DMSO + H2O (1:4)
n.d. n.d. 167.84 4 cereulide dissolved in 100 % 
DMSO + H2O (1:24)
n.d.: not determined
2.3.  Microtiter plate assay
The antimicrobial  effect  of  valinomycin  and cereulide  on  the  growth of  selected 
bacteria was assessed by the generation of spectrophotometric growth curves in 96-well 
microtiter plates (greiner bio-one, Germany). The effect of the pH and the availability of 
O2 on  these  ionophores  effectiveness  were  evaluated,  as  well  as  the  concentration  of 
ionophore used.
To have the same initial optical density (OD) of bacterial cells in all performed tests, 
cells of overnight cultures were resuspended in phosphate buffer (PPi, 0.01 M, pH 7.0) on 
the right proportion to obtain an OD600nm of 2. After inoculation, this OD resulted in an 
OD600nm of 0.1.
The microtiter plates were prepared as described below and incubated at 30°C in a 
plate reader (SpectraMax plus384) for 24 h. The OD600nm of each well was automatically 
recorded for every 5 minutes with shaking for 30 seconds before the first read and between 
each read. The changes in OD over time were used to generate growth curves.
2.3.1.  Effect of pH and O2 on valinomycin effectiveness
The effect  of pH on valinomycin effectiveness as an antibiotic  was evaluated by 
measuring bacterial growth at a range of pH values, 5.5, 6.5, 7.5, 8.5 and 9.5. The 96-well 
microtiter plates were prepared by dispensing 180 μl of BHI broth, with the intended pH, 
into a well to which an inoculum of 10 μl of bacterial cells resuspended in PPi (OD600nm=2) 
was added. Finally, 10 μl of valinomycin stock solution (179.97 μM in 20 % DMSO) was 
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added to each well, resulting in the final concentrations of 9 μM of valinomycin with 1 % 
v/v DMSO. As a blank control, DMSO solution (20 %) without valinomycin was used, 
obtaining a final concentration of 1 % v/v DMSO. Each condition was tested in triplicate. 
The  effect  of  O2 was  evaluated  by  growing  bacterial  cells  under  aerobic  and 
anaerobic conditions. Anaerobiosis was created by covering the 96 well plates with optical 
adhesive film (MicroAmp).
2.3.2.  Dose effect of valinomycin
Effect of 0.09, 0.90, 4.50, 9.00, 22.50 and 44.99 μM of valinomycin on the growth of 
B. cereus strains was evaluated at pH values of 5.5, 7.5, 8.5 and 9.5. 
The 96-well microtiter plates were prepared by dispensing 180 μl of BHI broth, with 
the intended pH, into a well to which an inoculum of 10 μl of bacterial cells resuspended in 
PPi  (OD600nm=2) was added.  Finally,  10  μl  of  valinomycin  stock solution (1.80,  18.00, 
89.98 and 179.97 μM in 20 % DMSO and 449.92 and 899.83 μM in 100 % DMSO) was 
added  to each well resulting in the final concentrations of  0.09, 0.90, 4.50 and 9.00 of 
valinomycin with 1 % v/v DMSO and 22.50 and 44.99 μM of valinomycin with 5 % v/v 
DMSO.
2.3.3.  Effect of cereulide on bacterial growth
The  effect  of  pH  on  cereulide  effectiveness  as  an  antibiotic  was  evaluated  by 
measuring growth of  B. subtilis,  L. monocytogenes,  B. cereus  ATCC 10987,  B. cereus 
ATCC 14579, B. cereus F4810/72 and L. innocua at a range of pH values, 5.5, 6.5, 7.5, 8.5 
and 9.5. The procedure was followed as above (), but, instead of valinomycin, cereulide 
stock solution was used (179.97 μM in 20 % DMSO).
2.3.4.  Effect of H2O on cereulide effectiveness
In order to evaluate the effect of H2O on the activity of cereulide, a stock solution of 
cereulide in 20 % DMSO (167.84  μM) and another in 100 % DMSO (839.84μM) were 
prepared.  Both solutions were used to assess the effect of cereulide on the growth of  B. 
cereus F4810/72, B. cereus 10987 and B. subtilis, at pH 8.5. 
A 96-well microtiter plate was prepared by dispensing 180 μl of BHI broth (pH 8.5) 
into a well to which an inoculum of 10 μl of bacterial cells resuspended in PPi (OD600nm=2) 
was added. Then, wells were filled with 10 μl of cereulide stock solution in 20 % DMSO 
(167.84  μM) or with  8  μl of H2O and 2  μl of cereulide stock solution in 100% DMSO 
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(839.84μM), obtaining, in both cases, a final concentration of  8.39 μM of cereulide with 1 
% v/v DMSO in each well. This was performed with fresh and 24 hours old solutions of 
cereulide.  As  a  blank  control,  DMSO  solution  (20  %)  without  cereulide  was  used, 
obtaining a final concentration of 1 % v/v DMSO. Each condition was tested in triplicate. 
2.3.5.  Data processing and statistical analysis
The OD600nm measurements from the plate reader run were imported into Microsoft 
Office  Excel  2003 and  corrected  by subtracting  the  background OD600nm of  the  growth 
media from the data  of each well.  The average growth curve was calculated and then 
plotted.
For each growth curve generated, the specific growth rate (μ) and the duration of the 
lag phase (lag) were fitted and determined using the Zwietering growth model (Zwietering 
et  al.  ,  1990),  referred  as  Equation  1.  In  this  equation the  A represents  the difference 
between the  maximum OD and the  initial  OD (ODt=0),  whereas  t  stands  for  the  time. 
Logarithmically transformed growth curves were fitted according to this model using the 
solver from Microsoft Office Excel 2003. The average μ and lag for each condition were 
then calculated, as well as their standard error.
Equation 1
Growth  rates  (μ) in  presence  of  valinomycin  and  cereulide  were  determined  as 
percentage of the control growth rate values (Equation 2), the acquired value was termed 
“relative growth rate  (RGR)”.  It  was also used to calculate the difference between the 
length of the lag phase of the growth control and the growth with ionophores (Equation 3).
100×=
control
testRGR
µ
µ
Equation 2
Δ lag = lagtest – lagcontrol Equation 3
Statistical  significance  of  differences  between  values  of  the  growth  parameters 
obtained from test and control conditions were determined using a two-tailed t-test and 
were considered significant when p<0.05. The selection between a paired or unpaired t-test 
was based on the F-test, considering p<0.05.
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2.4.  Paper disk assay
The evaluation of the susceptibility of B. subtilis, L. innocua, L. monocytogenes, E.  
faecalis, S. aureus, S. thyphimurium and E. coli to valinomycin and cereulide (supernatant 
of B. cereus A529 culture) was performed with a filter paper disk method. 
The cereulide extract was obtained by spinning 1 ml of  B. cereus  A529 overnight 
culture  at  13000 rpm for  1  minute.  Then  the  supernatant  was  filtered  with  a  0.2  μm 
cellulose acetate filter (Whatman, Germany).
Each bacterial strain was tested by pour-plating 1 ml of overnight culture in BHI agar 
(1.5  % w/v agar). After solidification,  a paper disk of 6 mm (Becton Dickinson, France) 
was placed on the surface of the plate.  The disks were saturated with 5  μl aliquots of 
valinomycin stock solution (9.00  μM in 1 % DMSO) or with filtered  supernatant of  B. 
cereus  A529 culture. The effect was quantified after 20 hours of incubation at 30°C by 
measuring the diameter of the inhibition zone.
2.5.  Drop dilution assay
2.5.1.  Effect of valinomycin and cereulide
A 1000-fold  dilution  of  overnight  cultures  of  B.  cereus ATCC 10987,  B.  cereus 
ATCC  14579,  B.  cereus A529,  B.  cereus F4810/72,  B.  subtilis,  L.  innocua,  L. 
monocytogenes and E. coli, was prepared using phosphate buffered saline (PBS, pH 7.37).
The sensitivity of the microorganisms to valinomycin and cereulide was tested on 
BHI agar with pH 7.5, 8.5 and 9.5. Briefly, 1 ml of overnight culture was pour-plated in 14 
ml of BHI agar  (1.5% w/v agar). After solidification, 5  μl of valinomycin (179.97 and 
899.83 μM in 4 % DMSO) or cereulide (167.84 μM in 4 % DMSO) stock solutions were 
spotted on the agar surface, in duplicate. As control, 5 μl of 4 % DMSO were spotted on 
the agar surface, also in duplicate. Petri dishes were prepared in duplicate and incubated 
overnight at 30°C. The antimicrobial activity was evaluated by measuring the diameter of 
the inhibition zone.
2.5.2.  Effect of B. cereus A529
The sensitivity of test strains to cereulide, likely to be produced by the emetic  B. 
cereus A529 strain, was tested by growing those strains in the presence of B. cereus A529, 
using two different methods. 
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Sensitivity of  B. cereus ATCC 10987,  B. cereus F4810/72,  L. monocytogenes,  E. 
faecalis and S. aureus to cereulide was evaluated by growing these strains, at different pH 
values (7.5, 8.5 and 9.5), over colonies of B. cereus A529. No growth or reduced growth of 
test  strains  over  the  colonies  of  B.  cereus  A529  might  indicate  growth  inhibition  by 
cereulide.
A 5 μl aliquot of B. cereus A529 culture was spotted, in quadruplicate, on the surface 
of 7.5 ml of BHI agar (1.5% w/v agar), in a Petri dish. After overnight incubation at 30°C, 
4 ml of melted BHI soft agar (0.5% w/v agar) inoculated with 1ml of overnight culture of 
test strains were overlaid on top of the BHI agar with the grown colonies. The BHI soft 
agar used had different pH values (7.5, 8.5 and 9.5). The plates were incubated again at 
30°C for ~16h.
Growth of B. cereus A529 occurred on top of cultures of B. cereus ATCC 10987, B. 
cereus ATCC 14579, B. cereus F4810/72, B. subtilis, L. innocua, L. monocytogenes and E. 
coli. Strain sensitivity was evaluated at different pH values (7.5, 8.5 and 9.5).
Overnight cultures of the test strains were diluted 1000-fold in PBS. Afterwards, 1 ml 
of each dilution was pour plated in 14 ml of BHI agar  (1.5% w/v agar) (pH 7.5, 8.5 and 
9.5). After solidification, 5 μl of B. cereus A529 overnight culture were spotted on the agar 
surface, in duplicate.  Petri dishes were prepared in duplicate and incubated overnight at 
30°C.  Absence  of  growth  or  reduced  growth  of  test  bacteria  around  B.  cereus  A529 
colonies might be an indicator of antimicrobial activity of cereulide. 
2.6.  Survival and recovery assay
The  effect  of  potassium  ionophores  on  survival  of  bacteria  (bacterial-cidal  or 
bacterial-static)  was  evaluated  by  determining  CFU  counts  of  bacterial  cultures  with 
simultaneous OD600nm measurement.  A decrease in  the number of  CFU may indicate  a 
bacterial-cidal effect,  while a bacterial-static effect  may result  in a constant number of 
CFU. A negative effect  on cell  survival followed by normal viable counts show a cell 
recovery.
2.6.1.  Effect of valinomycin on bacterial cell survival
B.  cereus ATCC  10987,  B.  cereus  ATCC  14579  and  B.  cereus F4810/72  were 
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exposed to valinomycin (9 μM) with 1 % v/v DMSO, at pH 8.5 and 9.5. A 2.5 ml aliquot of 
valinomycin  stock  solution  (179.97  μM  in  20  %  DMSO)  was  pipetted  into  250  ml 
Erlenmeyer flasks containing 45 ml of BHI broth (pH 8.5 or 9.5) previously inoculated 
with  2.5  ml  of  bacterial  suspension  in  PPi  (OD600nm= 2).  The  prepared  culture  had  an 
OD600nm of 0.1.  As a control, 20 % DMSO without test compound was added, resulting in a 
final concentration of DMSO of 1 % v/v. 
Each flask was prepared in duplicate and was incubated at 30°C in a shaking water 
bath at 200 rpm.
At several time points, between 30 min and 24 hours of incubation, 2 ml samples 
were taken aseptically from each culture  and 100-,  10000-  and 1000000-fold dilutions 
were  prepared  in  PBS.  In  each  sampling  time  point,  the  OD600nm of  each  culture  was 
measured.
2.6.2.  Effect of cereulide on bacterial cell survival
B. cereus ATCC 10987 and B. cereus F4810/72 were exposed to cereulide (8.39 μM) 
with 1 % v/v DMSO, at pH 8.5. A 0.1 ml aliquot of cereulide stock solution (839.18 μM in 
100 % DMSO) was dispensed into 50 ml Erlenmeyer flasks containing 0.4 ml of sterile 
H2O and 9 ml of BHI (pH 8.5) previously inoculated with 0.5 ml of bacterial suspension in 
PPi (OD600nm= 2). The prepared culture had an OD600nm of 0.1. As a control, cereulide and 
H2O were replaced by 0.5 ml of 20 % DMSO, resulting in the final concentration of 1 % v/
v. 
Each flask was prepared in duplicate and was incubated at 30°C in a shaking water 
bath at 200 rpm.
At several time points, between 30 min and 24 hours of incubation, 1ml samples 
were  taken  aseptically  from  each  flask  and  10-,  100-,  1000-,  10000-,  100000-  and 
1000000-fold dilutions were prepared in PBS. In each sampling time point, the OD600nm of 
each culture was measured.
2.6.3.  Plating and calculations
The appropriate dilutions were plated, in duplicate, on BHI agar plates by using a 
spiral  plater  (Eddy Jet;  IUL Instruments)  set  in  E-mode,  plating  50  μl  aliquots.  After 
overnight incubation at 30°C, colonies were enumerated and the number of CFU ml -1 and 
respective standard error were determined.
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The antimicrobial  effect  of  valinomycin  and cereulide  on  the  growth of  selected 
bacteria was assessed by the generation of spectrophotometric growth curves in 96-well 
microtiter plates (greiner bio-one, Germany). 
15
3. RESULTS 
3.1.  Antimicrobial activity of valinomycin
Growth of  test  bacteria  exposed to  valinomycin  in  BHI broth was monitored by 
measurement of their OD600nm, generating growth curves (see Appendix 1 and Appendix 2). 
These growth curves showed that all Gram positive strains tested, E. faecalis, S. aureus, L.  
innocua, L. monocytogenes, B. subtilis, B. cereus ATCC 10987, B. cereus ATCC 14579, B. 
cereus  F4810/72  and  B.  cereus  A529 suffered  growth  inhibition  by  9.00  μM  of 
valinomycin.  On  the  other  hand,  Gram  negative  bacteria  tested  (E.  coli  and  S.  
thyphimurium) were resistant to valinomycin. 
3.1.1.  Effect of pH on valinomycin effectiveness
Growth of bacteria in a range of pH values (5.5 to 9.5) showed that there is a relation 
between the pH of growth media and the intensity of the growth inhibition caused by 
valinomycin.  Excluding  E.  faecalis,  growth  inhibition  of  test  bacteria  by  valinomycin 
increased with the increase of the pH. At pH 5.5 and 6.5, this ionophore was less effective 
in growth inhibition than at alkaline pH. At pH 9.5, excluding  E. faecalis,  none of the 
Gram positive strains tested was able to grow in presence of valinomycin, aerobically, for 
at least 24h. 
Although  B.  cereus  strains  ATCC 14579  and  ATCC  10987  are  both  non-emetic 
strains, they exhibited different responses to valinomycin. While  B. cereus  ATCC 10987 
showed high sensitivity to valinomycin,  B. cereus  ATCC 14579 expressed much lower 
sensitivity to this compound.  Figure 4 illustrates the relative growth rate (RGR) and the 
increase on  length of  the lag phase caused by valinomycin (Δlag)  of  B. cereus  ATCC 
10987 (A), cereus ATCC 14579 (B) and Figure 5 illustrates the RGR and the Δlag of  B. 
cereus  F4810/72.  The  relative  growth  rate  values  are  proportionally  inverse  to  the 
inhibition values, a relative growth rate of 100 % indicates no inhibition and vice versa.
The response of B. cereus ATCC 14579 to valinomycin was found to be comparable 
with the response of the emetic strains. The emetic strains (B. cereus F4810/72 and A529) 
and the non-emetic B. cereus ATCC 14579 strain were the ones that showed less sensitivity 
to  valinomycin.  Their  growth  inhibition  was  similar  at  pH  5.5,  6.5  and  7.5,  with  all 
exhibiting a decrease of around 20 % in their growth rate. At pH 7.5, beside the decrease of 
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the growth rate, valinomycin also caused a small increase of the lag phase (≤ 3 hours). At 
pH 8.5, these strains were the only ones that did not experience a decrease of growth rate 
by the action of valinomycin. Although not negatively affected in growth rate, at this pH, 
strains suffered a lag phase of 9 to 13 hours (Figure 4B, Figure 5). Interestingly, B. cereus 
ATCC 14579 (Figure 4B) and B. cereus A529, after experiencing the lag phase, underwent 
a significant increase in their growth rate after exposure to valinomycin. See Appendix 3 
for more details.
Figure 4. Relative growth rate (RGR) and difference between the length of the lag phase of the growth 
control and the growth with valinomycin (Δlag) of B. cereus ATCC 10987 (A), and B. cereus ATCC 14579 
(B) exposed to 9 μM of valinomycin and 1 % DMSO in BHI broth at different pHs, at 30°C, with aeration. 
Red line (RGR = 100 %) indicates no inhibition. Statistical significant difference between growth control and 
growth test (*), p<0.05.
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Figure 5. Relative growth rate (RGR) and difference between the length of the lag phase of the growth 
control and the growth with valinomycin (Δlag) of B. cereus F4810/72 exposed to 9 μM of valinomycin and 
1 % DMSO in BHI broth at different pHs, at 30°C, with aeration. Red line (RGR = 100 %) indicates no 
inhibition. Statistical significant difference between growth control and growth test (*), p<0.05.
The reaction of the non-emetic B. cereus ATCC 10987 to valinomycin was similar to 
that of  B. subtilis,  L. monocytogenes, L. innocua  and  S. aureus which all exhibited high 
sensitivity to valinomycin. At pH 6.5, exposure to valinomycin resulted in a 50 % decrease 
in growth rate of B. cereus ATCC 10987 (Figure 4A) and an inhibition of approximately 30 
% for the other sensitive strains. At pH 7.5, excluding B. subtilis which was more affected 
on its lag time, the sensitive strains suffered an inhibition of 40 to 70% on their growth rate 
after exposure to 9.00 μM of valinomycin. See Appendix 3 for more details.
E. faecalis  showed a response to valinomycin completely different from the other 
Gram positive bacteria. It was at acidic pH that valinomycin caused the highest growth 
inhibition (9.00  μM valinomycin, pH 5.5) suffering a decrease of more than 80% on its 
growth rate. At alkaline pH, its growth rate suffered an inhibition of around 30% (Figure
6).  Exposure of  E. faecalis  to valinomycin resulted also in a significant decrease of the 
maximum OD600 reached, indicating a lower cell density. Its lag phase was not affected 
by valinomycin. See Appendix 1 for more details.
18
Figure 6. Relative growth rate (RGR) of E. faecalis after exposure to 9 μM of valinomycin in BHI agar at 
different pHs, at 30°C, under aerobic and anaerobic conditions. Red line (RGR = 100 %) indicates no 
inhibition. Growth rates from growth control and growth test were statistical different (p<0.05).
Figure 7.  Anaerobic growth of B. cereus F4810/72 in BHI broth, at pH 8.5 and 9.5, with and without 9 μM 
of valinomycin and with 1% DMSO.
3.1.2.  Effect of O2 on valinomycin effectiveness
The antimicrobial activity of valinomycin was evaluated under aerobic and anaerobic 
conditions. Under both conditions, addition of 9.00 μM of valinomycin exhibited growth 
effects against Gram positive strains tested. However, excluding  E. faecalis, the level of 
inhibition by valinomycin under anaerobic conditions was found to be lower than under 
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aerobic  conditions.  These  results  are  illustrated  on  Figure  7 that  shows the  difference 
between  growth  curves  of  oxygenated  and  non-oxygenated  B.  cereus  F4810/72  cells. 
Control  growth  was  similar  under  both  conditions.  See  Appendix  1,  Appendix  2  and 
Appendix 3 for more details.
In opposition to the other test strains,  E. faecalis  suffered more growth inhibition 
under anaerobic conditions that under aerobiosis (Figure 6).
3.1.3.  Dose effect of valinomycin
Growth of B. cereus strains was evaluated in the presence of a range of valinomycin 
concentrations. The results exhibited by the sensitive B. cereus ATCC 10987, in the form 
of growth comparatively to the control, are shown in  Figure 8.  Results  from the other 
strains can be seen in Appendix 4. Aerobic growth of B. cereus strains was not affected by 
concentrations  of  valinomycin  lower  than  0.90  μM.  However,  when  submitted  to  the 
presence of 4.5  μM of valinomycin or higher concentrations, these strains suffered some 
growth inhibition. The highest concentrations of valinomycin tested (22.50 and 45.00 μM) 
were responsible for the highest antimicrobial activity against B. cereus strains, preventing 
outgrowth,  at  pH  9.5,  for  at  least  24  hours.  Nevertheless,  these  two  solutions  of 
valinomycin contained 5 % of DMSO which caused, by itself, some growth inhibition.
3.1.4.  Dose effect of valinomycin
Growth of B. cereus strains was evaluated in the presence of a range of valinomycin 
concentrations. The results exhibited by the sensitive B. cereus ATCC 10987, in the form 
of growth comparatively to the control, are shown in  Figure 8.  Results  from the other 
strains can be seen in Appendix 4. Aerobic growth of B. cereus strains was not affected by 
concentrations  of  valinomycin  lower  than  0.90  μM.  However,  when  submitted  to  the 
presence of 4.5  μM of valinomycin or higher concentrations, these strains suffered some 
growth inhibition. The highest concentrations of valinomycin tested (22.50 and 45.00 μM) 
were responsible for the highest antimicrobial activity against B. cereus strains, preventing 
outgrowth,  at  pH  9.5,  for  at  least  24  hours.  Nevertheless,  these  two  solutions  of 
valinomycin contained 5 % of DMSO which caused, by itself, some growth inhibition.
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Figure 8. Relative growth rate – RGR (A) and difference between the length of the lag phase of the growth 
control and the growth with valinomycin – Δlag (B) of B. cereus ATCC 10987 exposed to a range of 
valinomycin concentrations (0.09 to 44.99 μM) and 1 or 5 % of DMSO, in BHI broth at different pHs, at 
30°C, with aeration. Red line (RGR = 100 %) indicates no inhibition. Statistical significant difference 
between growth control and growth test (*), p<0.05.
3.1.5.  Paper disk and drop dilution assays
The susceptibility of bacteria to valinomycin was also evaluated in solid media, by 
two different approaches. A drop of valinomycin solution was placed on paper disks (9 μM 
of valinomycin with 1% DMSO) or directly on the bacterial culture (179. 97 and 899.83 
μM of valinomycin with 4 % DMSO). 
Using the method of paper disk diffusion, inhibition of tested bacteria (B. subtilis, L.  
innocua, L. monocytogenes, E. faecalis, S. aureus, S. thyphimurium and  E. coli) was not 
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observed. 
The sensitivity of  B. cereus  F4810/72,  B. cereus  A529,  B. cereus  ATCC 10987,  B. 
cereus  ATCC 14579,  B. subtilis,  L. monocytogenes  and L. innocua to valinomycin was 
observed after this compound (179.97 and 899.83 μM) was spotted on the surface of the 
bacterial cultures. The diameter of inhibition zones is shown in Table 4. In general, the 
largest inhibition of test strains was caused by the higher concentration of valinomycin 
used (899.83 μM) and at pH 8.5. 
In B. cereus strains, valinomycin was able to prevent the development of colonies at 
the surface of medium, but inside the medium, in the less oxygenated layer, development 
of colonies was observed. Emetic strains showed to be less susceptible to valinomycin, 
being resistant to 179.97 μM of valinomycin at pH 7.5. On the other hand, at pH 8.5, the 
non-emetic B. cereus ATCC 10987 strain was quite sensitive to valinomycin. On Figure 9, 
inhibition caused by valinomycin in B. cereus F4810/72 (A) and in B. cereus ATCC 10987 
(B) can be compared. See Appendix 5 for more figures.
B. subtilis showed higher sensitivity to valinomycin, exhibiting no growth at pH 7.5 
(Figure 10A) and 8.5 (Figure 10B) in the presence of valinomycin. At pH 8.5, this strain 
exhibited the largest inhibition zone observed (Figure 10). 
At pH 9.5, only Listeria strains and B. cereus F4810/72 showed uniform growth in 
the plate. All other strains exhibited insufficient growth at this pH making it impossible to 
determine the growth effects of valinomycin at this pH. 
Figure 9. Inhibition zones caused by 179.97 μM (a) and 899.83 μM (b) of valinomycin in B. cereus  F4810/72 
ATCC (A) and B. cereus  ATCC 10987 (B) cultures in BHI agar, at pH 8.5, after 14 h of growth at 30°C. 
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Figure 10. Inhibition zones caused by 179.97 μM (a) and 899.83 μM (b) of valinomycin in B. subtilis cultures in 
BHI agar, at pH 7.5 (A) and at pH 8.5 (B), after 14 h of growth at 30°C.
Table 4. Inhibition zone (mm±SE) resultant from exposure of test bacteria to valinomycin in BHI agar, after 
14h of incubation at 30ºC.
Microorganism
Valinomycin
179.97μM 899.83μM
pH 7.5 pH 8.5 pH 9.5 pH 7.5 pH 8.5 pH 9.5
B. cereus 10987 5.4±0.6 1 8.4±0.0 n.d. 7.5±0.3 1 7.8±0.0 n.d.
B. cereus 14579 4.0±0.0 2 6.5±1.31 n.d. 4.7±0.0 2 6.5±0.01 n.d.
B. cereus F4810/72 0 6.9±0.01 11.2±0.4 6.2±0.0 1 6.9±0.01 10.7±0.0
B. cereus A529 0 7.2±0.31 n.d. 0 8.1±0.01 0
B. subtilis 7.7±0.3 10.5±0.0 n.d. 7.3±0.0 11.9±0.5 0
L. monocytogenes 7.3±0.0 2 7.6±0.3 1 1.00±0.0 7.3±0.02 9.4±0.3 10.3±0.3
L. innocua 9.0±0.6 1 8.8±0.0 1.20±0.0 9.6±0.0 10.8±0.7 12.0±0.2
E. coli 0 0 0 0 0 0
n.d. (not determined): insufficient growth of test bacteria
1: not complete inhibition, some colonies present
2: slight inhibition, many colonies present
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3.2.  Strain sensitivity to B. cereus A529
The susceptibility of   B. cereus  ATCC 10987,  B. cereus  F4810/72, E. faecalis, L.  
monocytogenes,  and S. aureus  to cereulide,  produced by growing cultures of  B. cereus 
A529, was evaluated by growing these strains in semi-solid BHI top-agar (pH 7.5, 8.5 and 
9.5), which was applied over the pre-grown (27 hours) colonies of B. cereus A529 . All of 
the strains tested showed some sensitive to B. cereus A529, but it was not significant. 
In another method, the growth of test bacteria and of emetic strain started at same 
time. Colonies of the emetic  B. cereus  A529 strain were spotted and grown on the BHI 
agar surface (pH 7.5, 8.5 or 9.5) previously inoculated with approximately 105 CFU/ml of 
B.  cereus ATCC  10987,  B.  cereus ATCC  14579,  B.  cereus F4810/72,  B.  subtilis,  L. 
innocua,  L.  monocytogenes or  E.  coli.  The  results  showed  that  the  emetic  B.  cereus 
F4810/72 strain was unable to grow around the colonies of B. cereus A529 (Figure 11) and 
L. monocytogenes (Figure 12) and L. innocua (Figure 13) exhibited a reduced density of 
cells around that colonies. The inhibition caused by the presence of B. cereus  A529 was 
dependent of the media pH, which increased at higher pH. The other strains tested were not 
affected by the presence of the colonies of B. cereus A529.
Figure 11. Inhibition of B. cereus F4810/72 growth by B. cereus A529 (center), on BHI agar, at pH 7.5.
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Figure 12. Inhibition of L. monocytogenes growth by B. cereus A529 (center), on BHI agar, at pH 8.5.
Figure 13. Inhibition of Listeria innocua growth by Bacillus cereus A529 (center), on BHI agar, at pH 8.5.
3.3.  Antimicrobial activity of cereulide
3.3.1.  Effect of supernatant of B. cereus A529
The susceptibility of B. subtilis, L. innocua, L. monocytogenes, E. faecalis, S. aureus, 
S. thyphimurium and E. coli to cereulide was initially evaluated by dropping filter sterilized 
supernatant of  B. cereus  A529 on paper disks, previously placed on bacterial cultures on 
BHI  agar.  After  a  period  of  20  hours  at  30°C,  no  inhibition  of  these  strains  by  the 
supernatant was observed. 
3.3.2.  Effect of cereulide
The variation of OD600nm in aerobic bacterial growth in BHI broth, with addition of 
25
cereulide (179.97 μM in 20 % DMSO) from a fresh stock solution, showed that B. cereus  
ATCC 10987, B. subtilis and L. monocytogenes experienced growth inhibition by 9 μM of 
this ionophore. On the other hand, B. cereus F4810/72,  B. cereus A529, B. cereus ATCC 
14579 and L. innocua, which were submitted to cereulide from a solution stored for 24-48 
hours, did not suffer any growth inhibition.
3.3.3.  Effect of H2O on cereulide effectiveness
Growth  of  B.  cereus  F4810/72, B.  cereus 10987  and  B.  subtilis  occurred 
simultaneously in presence of cereulide from two different stock solutions (167.84 μM in 
20 % DMSO and 167.84 μM in 100 % DMSO). Growth was recorded with fresh and 24 
hours old solutions of cereulide.
The results obtained revealed that the 24 hours old solution of cereulide in 20 % 
DMSO had no effect on the growth of B. cereus 10987 and B. subtilis, in opposition to the 
solution of cereulide in 100% DMSO. Both fresh solutions of cereulide caused growth 
inhibition of B. cereus 10987 and B. subtilis, but the solution of cereulide in 20 % DMSO 
was less effective. Figure 14 and Figure 15 represent the growth curves of B. cereus ATCC 
10987 and B. subtilis, respectively, resultant from their growth with cereulide dissolved in 
20 % DMSO and dissolved in 100 % DMSO.  
In opposition to B. cereus 10987 and B. subtilis, B. cereus F4810/72 was resistant to 
8.39 μM of cereulide, at pH 8.5 (Figure 16).
Figure 14. Aerobic growth of B. cereus ATCC 10987 in BHI broth, at pH 8.5, with addition of cereulide in 
20 and 100% DMSO from a 24 hours old solution (final concentration 1% DMSO with 8.39 μM of 
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cereulide).
Figure 15. Aerobic growth of B. subtilis in BHI broth, at pH 8.5, with addition of cereulide in 20 and 100% 
DMSO from a 24 hours old solution (final concentration 1% DMSO with 8.39 μM of cereulide).
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Figure 16. Aerobic growth of B. cereus F4810/72 in BHI broth, at pH 8.5, with and without 8.39 μM of 
cereulide and 1% DMSO.
3.4.  Drop dilution assay 
Cereulide (167.84  μM in 4 % DMSO), spotted on BHI agar inoculated with test 
bacteria, caused some inhibition on the growth of the Gram positive non-emetic strains. 
Diameter of inhibition zones is shown in Table 5. However, this ionophore was only able 
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to cause a decrease in cell density without complete inhibition of growth. Inhibition of B.  
cereus  ATCC 10987 (Figure 17A),  B. cereus  ATCC 14579 (Figure 17B) and  B. subtilis  
(Figure 18) was observed at pH 8. Both Listeria strains were inhibited at pH 7.5 (Figure
19A),  8.5  (Figure  19B)  and 9.5.  At  pH 8.5,  all  the  inhibited  strains  exhibited  similar 
inhibition  zones,  without  significant  differences  between  the  results  of  the  non-emetic 
strains, B. cereus ATCC 10987 and ATCC 14579.
Figure 17. Inhibition zones caused by cereulide (167.84 μM) in cultures of B. cereus ATCC 10987 (A) and 
B. cereus ATCC 14579 (B) in BHI agar, at pH 8.5, after 14 h of growth at 30°C.
Figure 18. Inhibition zones caused by cereulide (167.84 μM) in B. subtilis culture in BHI agar, at pH 8.5, 
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after 14 h of growth at 30°C.
Figure 19. Inhibition zones caused by cereulide (167.84 μM) in cultures of L. innocua at pH 7.5 (A) and L. 
monocytogenes at pH 8.5 (B), both in BHI agar, after 14 h of growth at 30°C.
Table 5. Inhibition zone (mm±SE) resultant from exposure of test bacteria to cereulide in BHI agar, after 14h 
of incubation at 30ºC.
Microorganism
Cereulide (167.84μM)
pH 7.5 pH 8.5 pH 9.5
B. cereus 10987 0 6.6±0.3 2 n.d.
B. cereus 14579 0 6.3±0.0 2 n.d.
B. cereus F4810/72 0 0 0
B. cereus A529 0 0 n.d.
B. subtilis 0 6.5±0.0 2 n.d.
L. monocytogenes 5.1±0.0 2 6.5±0.3 2 5.3± 0.31
L. innocua 6.5± 0.02 6.8±1.4 1 6.6±0.3 1
E. coli 0 0 0
n.d. (not determined): insufficient growth of test bacteria
1: not complete inhibition, some colonies present
2: slight inhibition, many colonies present
3.5.  Effect of potassium ionophores on bacterial survival
In growth curves that exhibited long lag phases, a drop in absorbance was generally 
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observed (See Appendix 1 and Appendix 2). To verify if that drop in absorbance was a 
consequence of cell death, the number of CFU of cultures of  B. cereus  ATCC 10987,  B. 
cereus ATCC 14579 and B. cereus F4810/72 was determined.
3.5.1.  Effect of valinomycin
Growth of B. cereus ATCC 10987, B. cereus ATCC 14579 and B. cereus F4810/72 
occurred in BHI, at pH 8.5 and 9.5, in presence of 9 μM of valinomycin in 1 % DMSO.
At pH 8.5, valinomycin caused a decrease of the number of CFU of all strains tested. 
The same was observed at pH 9.5, but, at this pH, CFU counts of control growth also 
suffered a decrease.
The  non-emetic  B.  cereus  ATCC  10987  was  the  most  susceptible  strain  to 
valinomycin. At pH 8.5, in 2 hours of exposure to valinomycin, it suffered more than 3.5 
log reduction of the initial number of CFU/ml. Recovery of CFU occurred more than 8 
hours after the beginning of exposure to the ionophore (Figure 20). On the other hand, the 
emetic B. cereus F4810/72 undered a low percentage of mortality induced by valinomycin, 
suffering less than 1 log reduction of the initial number of CFU/ml (Figure 21). In 6 hours 
of exposure to  valinomycin,  non-emetic  B. cereus  ATCC 14579 experienced a  2.4 log 
reduction of the initial number of CFU/ml. Recovery of CFU occurred immediately after 
that period.  Decrease of the number of CFU/ml of cultures of B. cereus F4810/72 and B. 
cereus  A529 with valinomycin was found only at the moment that CFU numbers of the 
control growth started increasing. 
All strains were able to recovery from reduction of the number of CFU caused by 
valinomycin, at pH 8.5. After a 24 hours period of incubation, there were no significant 
differences between the number of CFU/ml of cultures with and without valinomycin. 
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Figure 20. CFU counts of B. cereus ATCC 10987 cultures exposed to 9 μM of valinomycin in BHI broth, 
at pH 8.5.
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Figure 21. CFU counts of B. cereus F4810/72 cultures exposed to 9 μM of valinomycin in BHI broth, at 
pH 8.5.
3.5.2.  Effect of cereulide
The effect  of cereulide (8.39  μM in 1% DMSO) on survival of  B. cereus  ATCC 
10987 and  B. cereus  F4810/72 growing in BHI broth, at pH 8.5, was also evaluated by 
determining the number of CFU. The viable counts of B. cereus ATCC 10987 showed that 
cereulide caused at least 2.5 log reduction of the initial number of CFU/ml, but recovery of 
CFU occurred after less than 6 hours of exposure to cereulide (Figure 22). After a 24 hours 
period  of  incubation,  cultures  with  and  without  cereulide  had  identical  numbers  of 
CFU/ml. Contrarily to the non-emetic strain, number of CFU/ml of cultures of B. cereus  
F4810/72 was not significantly affected by cereulide, being similar with the control ones 
(Figure 23).
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Figure 22. Viable counts of B. cereus ATCC 10987 cultures exposed to 8.39 μM of cereulide in BHI broth, 
at pH 8.5.
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Figure 23. Viable counts of B. cereus F4810/72 cultures exposed to 8.39 μM of cereulide in BHI broth, at 
pH 8.5.
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4. DISCUSSION 
4.1.  Antimicrobial activity of valinomycin
Valinomycin  is  a  potassium ionophore  with  known antimicrobial  activity  against 
Gram positive bacteria, as confirmed in this study. The inhibition of  E. faecalis  by this 
ionophore was already reported (Harold and Baarda,  1967; Seschachalem  et  al.,  1973; 
Ryabova et al., 1975) as well as the inhibition of B. subtilis (Seschachalem et al., 1973 and 
Ryabova  et  al.,  1975).  Bacillus  subtilis also  experienced  reversal  loss  of  its  motility 
induced by this ionophore (Shioi et al., 1978). Staphylococcus aureus, which, in this study, 
was sensitive to 9 μM of valinomycin (pH 7.5), has shown, in previous studies, different 
susceptibility to valinomycin.  According to Seschachalem et al. (1973), S. aureus growing 
in trypticase soy broth media is not sensitive to at least 90  μM of valinomycin. On the 
other hand, Ryabova and colleagues (1975) observed the inhibition of S. aureus at pH 7.2 
exposed to 0.2 (200 mM of K+) and 10 μM (5 mM of K+) of ethanolic valinomycin in a 
broth medium.
The resistance of Gram negative bacteria to valinomycin has been observed in other 
studies (Seschachalem et al., 1973, Ryabova et al., 1975). This resistance is probably due 
to the presence of an outer membrane that may prevent the entry of ionophores in the cell. 
This hypothesis is supported by the study of Pavlasova and Harold (1969), in which E. coli 
became  sensitive  to  valinomycin  after  treatment  with  Tris-EDTA,  which  increases  the 
permeability of the outer membranes.
Bactericidal activity of valinomycin, observed in this study, is a novelty. Until now, 
bactericidal effects of valinomycin were not known. However, only a partial cell death was 
observed, since all strains, after a period of cell death, were able to reach identical cell 
numbers to control growth.  Although bactericidal activity of valinomycin had not been 
tested at a pH lower than 8.5 it is unlikely that,  in relation to the results obtained, this 
ionophore causes cell death. From the tested bacteria, B. subtilis is the only one that may 
suffer  cell  death  by valinomycin  at  lower  pH predicted  from the  characteristics  of  its 
growth curve, at pH 7.5. Shioi and colleagues (1978) did not find a significant loss of 
viability of  B. subtilis cells  submitted to  the presence of  valinomycin (9 µM),  but  the 
analysis was done only during the first 10 minutes of exposure to this ionophore. In this 
study, bactericidal effects of valinomycin were observed only after 30 minutes of exposure 
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to valinomycin.
The apparent relation between cell death of  B. cereus  ATCC 14579 and F4810/72 
strains and cell growth suggests that the survival of these strains is not affected when they 
are  in a stage of low energy consumption. However, as soon as cell division starts, cells 
start  dying.  Cell  division  involves  synthesis  of  all  the  components  of  a  cell  (e.g.  cell 
membrane and DNA), which requires a high consumption of ATP and nutrients (Goehring 
and  Beckwith,  2005).  Valinomycin,  due  to  its  ionophoric  properties,  dissipates  the 
membrane potential  which,  at  pH 8.5,  will  result  in  the  decrease  or  dissipation  of  the 
proton motive force. Most likely, these cells can maintain a minimal proton motive force 
required for cell survival. However, this driving force should be not enough to allow the 
synthesis of ATP and uptake of nutrients required for a stage of high energy consumption, 
like  cell  division  is.  Therefore,  with  the  beginning  of  division,  cells  could  experience 
exhaustion of ATP and nutrients which were required for their survival, and will dye.
In  opposition  to  the  drop  dilution  assay,  evaluation  of  antimicrobial  activity  of 
valinomycin by performing the disk assay did not generate good results. Two factors can 
be associated with these bad results. The diffusion of the concentration of valinomycin (9 
μM) used in agar media could have result in a harmless concentration for cells. Moreover, 
the use of paper disks allows the observation of a possible inhibition only around the disk.
4.2.  Antimicrobial activity of cereulide
Cereulide is known for its ability to inhibit mitochondrial activity (Mikkola  et al., 
1999) and even for induction of apoptosis in cell lines (Morrison et al., 2005) but there are 
no references to cereulide as an antimicrobial compound, although this had already been a 
subject of study (Altayar and Sutherland, 2006). 
The results  obtained show that cereulide,  like valinomycin,  exhibits antimicrobial 
activity,  which  was  expressed  against  B.  cereus  ATCC  10987,  B.  subtilis  and L.  
monocytogenes,  at pH higher than 7.5. Cereulide was even found to cause cell death, at 
least of B. cereus ATCC 10987 cells growing in BHI broth at pH 8.5. Tests with B. cereus  
F4810/72 suggest that cereulide does not enhance the growth of its producer. Although B. 
cereus  A529,  B. cereus  ATCC 14579 and  L. innocua  had shown resistance to cereulide, 
those results are not trustable, since cereulide used on those tests was dissolved and stored 
in H2O. As it was later on confirmed, the antimicrobial activity of cereulide is lost when 
34
this hydrophobic compound is dissolved in H2O. The hydrophobic character of cereulide, 
when coming in contact to water, most likely result in aggregation of the compound or 
starts sticking to tube walls, consequentially losing its activity before adding it to a cell 
culture.
Although  cereulide  had  shown  antimicrobial  activity,  the  pH  at  which  it  was 
observed is an uncommon pH for bacterial growth. Substrate colonized by B. cereus such 
as food, has a pH below 7.5 (Adams and Moss, 2008). The soil may be the substrate where 
a more alkaline pH can be found, since its  normal pH values are in a range of 3 to 8 
(Breemen and Buurman, 2002). However, it was observed that the non emetic  B. cereus  
ATCC  14579 strain  has  the  ability  to  increase  the  extracellular  milieu  to  a  value  of 
approximately 8 (Nakata and Halvorson, 1960; de Vries et al., 2004). The increase of the 
media pH starts  during the early stationary phase (de Vries  et al.,  2004),  which is  the 
moment at which production of cereulide takes place. In this study, B. cereus ATCC 14579 
revealed a response to  valinomycin similar  to the response of emetic  strains.  Thereby, 
emetic  strains  may  also  cause  an  increase  of  extracellular  pH,  creating  the  perfect 
conditions for cereulide to inhibit the growth of competitors.  Moreover, it was reported 
that  cereulide  production  occurs  in  BHI  at  pH  6.0-6.8  but,  when  compared  with  its 
production at pH 7.4, the synthesis is slower (Rajkovic et al., 2006). This may support the 
hypothesis of cereulide being an antimicrobial compound. If cereulide inhibits bacterial 
growth only at  alkaline pH, its  production must be enhanced at  this  pH. The delay in 
cereulide production at acidic pH can also be related with a longer time needed to increase 
the pH to an optimal pH for cereulide activity. 
4.3.  Antimicrobial activity of cereulide likely produced by B. cereus A529
The lack of susceptibility  of  B. subtilis, L. innocua,  L. monocytogenes, E. faecalis  
and S. aureus  to the filtered supernatant of  B. cereus  A529 culture might be due to the 
absence of cereulide in the supernatant.  It  was reported that,  after  centrifugation of an 
emetic strain culture, the majority of cereulide produced remains in the pellet, whereas the 
filter-sterilized supernatant contains no cereulide (Rajkovic et al., 2006).
The effect of cereulide likely produced by the emetic B. cereus A529 strain on cell 
growth of other bacterial  strains was evaluated by growing cultures of  B. cereus  A529 
together  with  cultures  of  B.  cereus ATCC  10987,  B.  cereus ATCC  14579,  B.  cereus 
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F4810/72, B. subtilis,  L. innocua,  L. monocytogenes, E. faecalis  or S. aureus. The results 
obtained do not elucidate if  in vivo cereulide acts or not as an antibiotic. Inhibition of L.  
monocytogenes  and of  L.  innocua  was  observed.  However,  B.  cereus  F4810/72 strain, 
which showed resistance to cereulide, was also inhibited by B. cereus A529. Therefore, it 
is not clear if the inhibition observed was caused or not by cereulide.
4.4.  Effect of pH on growth inhibition by valinomycin and cereulide
In this study, growth inhibition by valinomycin and cereulide was greatly enhanced 
by raising the alkalinity of growth media.  In opposition to acidic medium, at neutral and 
alkaline  medium the  pH  gradient  across  the  cytoplasmic  membrane  of  bacterial  cells 
disappears.  Hence,  at  these conditions  the  proton  motive force depends mainly on the 
membrane  potential  (Weerkamp  et  al.,  1977).  Potassium  ionophores  stimulate  the  K+ 
movements across cytoplasmic membrane, down a concentration gradient (Lehninger  et  
al., 1993; Morrison et al., 2005). Then, treatment of bacterial cells with valinomycin and 
cereulide causes dissipation of membrane potential, but without affecting the pH gradient 
(Weerkamp  et  al.,  1977;  Morrison  et  al.,  2005).  Therefore,  in  presence  of  potassium 
ionophores,  the  proton motive  force  is  abolished  at  neutral  and  alkaline  pH values  of 
growth media, but not at acidic pH. Since the proton motive force is the driving force for 
proton  movements  which  in  turn  drives  nutrient  uptake  and  ATP synthesis  (respiring 
bacteria) (Harold, 1977), its dissipation will disturb these two essential processes for cell 
growth and survival and, consequently, bacterial growth is inhibited at neutral end alkaline 
pH.
4.5.  Effect of O2 on growth inhibition by valinomycin 
Although valinomycin had caused growth inhibition of bacteria growing aerobically 
and anaerobically, with the exception of  E. faecalis, this potassium ionophore was more 
effective  against  bacteria  growing  under  aerobic  conditions.  The  availability  of  O2 
(Kashket, 1981; Tran and Unden, 1998) as well as the presence or absence of a functional 
electron transport chain (ETC) determine how ATP is synthesized, if by aerobic respiration 
(+O2, +ETC), by anaerobic respiration (-O2, +ETC) or by fermentation (-O2, -ETC). With 
the exception of E. faecalis, which lacks a functional electron transport chain (Harold and 
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Baarda,  1967;  Harold,  1972),  all  the  tested  strains  perform  aerobic  respiration  under 
aerobic  conditions.  Under  anaerobiosis,  all  of  these  strains  are  able  to  ferment.  Since 
respiring  and  fermentative  bacteria  establish  a  proton  motive  force  by  different 
mechanisms  (Kashket,  1981),  this  driving  force  acts  differently  in  both  types  of  cells. 
Respiring bacteria require a proton motive force to synthesize ATP and to uptake nutrients, 
while  for  fermentative  bacteria  this  driving  force  is  directly  required  only for  nutrient 
uptake.  Therefore,  the  abolishment  of  the  proton  motive  force  by valinomycin  causes 
higher inhibition in respiring bacteria than in fermentative cells.
4.6.  Effect of valinomycin on E. faecalis growth
In agreement with previous studies (Gale, 1971; Ryabova et al., 1975),  E. faecalis  
exhibited a response to valinomycin opposite to the one exhibited by the other bacterial 
strains. This strain suffered stronger inhibition at acidic pH, while the inhibition of the 
other  strains  was  enhanced  by  raising  the  alkalinity  of  growth  media.  As  already 
mentioned, this microorganism has the peculiarity of lacking a respiratory chain. Thereby, 
the  proton  motive  force  is  generated  by  the  extrusion  of  protons  through  the  ATPase 
whether in anaerobiosis or aerobiosis (Harold and Baarda, 1967; Harold, 1972). Ryabova 
and colleagues (1975) demonstrated that valinomycin induces a decrease of the internal 
concentration of potassium in  E. faecalis cells, in contrast to respiring cells. Due to the 
positive charge of K+ and to the membrane potential  (inside negative),  an influx of K+ 
induced by valinomycin would be expected, not an efflux. However, fermentative bacteria 
have a lower proton motive force when compared with respiring bacteria (Kashket, 1981; 
Booth, 1985; Tran and Unden, 1998). These facts suggest that the proton motive force, 
generated during fermentation, may be insufficient to cause the influx of K+ against its 
concentration gradient. Therefore, the complex K+-valinomycin will flow according to the 
gradient concentration of potassium. The efflux of K+ will cause the hyperpolarization of 
its membrane with consequent induction of the influx of protons. The influx of protons is 
facilitated at acidic media pH, but is reduced during alkalinization of the external milieu 
(Harold and Baarda, 1967; Ryabova et al., 1975). Then, the higher inhibition of E. faecalis 
at acidic pH must be due to the higher influx of protons at this pH resulting in inhibition of 
the glycolysis by lowering internal pH (Harold and Baarda, 1967). 
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4.7.  Effect of valinomycin on B. cereus  growth
In this  study,  emetic strains showed less sensitivity to valinomycin than the non-
emetic strains tested (excluding B. cereus ATCC 14579). As expected, cereulide producer 
strains were resistant to this ionophore, in opposition to non-emetic strains studied. These 
results suggest that emetic strains must possess some mechanism to enable self-protection 
against  the  inhibitory  effect  of  cereulide.  This  mechanism  (most  likely  a  multidrug 
resistance/efflux  pump)  could  be  specific  to  cereulide  but,  probably  because  of  the 
structural  similarities,  works also against  valinomycin,  although less efficiently.   Lactic 
acid bacteria, which produce bacteriocins, have ABC-transport proteins that give them self-
protection against the bacteriocin by transporting its molecules back to the extracellular 
medium, when they enter the cell (Kraaij et al., 1999; Chen and Hoover, 2003). Sequence 
analysis  of  the  cereulide  synthetase  (ces)  gene  cluster,  which  is  responsible  for  the 
biosynthesis of cereulide, shows that 2 of the open reading frames encoded in this gene 
cluster,  cesC and cesD, seem to encode an ABC transporter  (Ehling-Schulz et al., 2006). 
This suggests that emetic strains might have a similar mechanism of self-protection like the 
one of lactic acid bacteria, which may act alone or in combination with other mechanisms.
The non-emetic B. cereus ATCC 14579 exhibited less sensitivity to valinomycin than 
the other non-emetic strains, being its response to valinomycin more comparable with the 
one of the cereulide producer strains. But the most interesting results were obtained from 
the  comparison  of  the  inhibition  of  B.  cereus  ATCC 14579  by  valinomycin  with  the 
inhibition of  B. cereus  ATCC 10987. Despite their  similarities,  B. cereus  ATCC 10987 
exhibited much higher sensitivity to valinomycin than B. cereus ATCC 14579.  B. cereus 
ATCC  14579,  contrary  to  ATCC  10987  strain,  can  metabolize  a  large  number  of 
carbohydrates (Mols et al, 2007) which could supply a growth advantage for this strain in 
starchy foods. As cereulide has been found essentially in starchy foods (Ehling-Schulz et  
al., 2004; Adams and Moss, 2008), it is possible that emetic strains colonize mainly this 
type of food. Thereby, the competition between B. cereus ATCC 14579 and emetic strains 
for the same habitat and nutrients could have resulted, by a process of natural selection, in 
a non-emetic strain able to minimize the inhibitory effect  of ionophores on its growth. 
Bacteria  have  developed  multidrug  resistance  pumps  which  provide  them  protection 
against toxins and antibiotics (Stavri et al., 2007). B. cereus ATCC 14579, in opposition to 
B.  cereus  ATCC  10987, could  have  a  multidrug  transporter  with  some  affinity  to 
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valinomycin and cereulide.  Since the genomes of  B. cereus  ATCC 10987 (Rasko  et al., 
2004)  and  B. cereus  ATCC 14579 (Ivanova  et  al.,  2003)  are  completely sequenced,  a 
microarray platform comparison could be done to try to find out which mechanism(s) of B. 
cereus ATCC 14579 confers some tolerance to potassium ionophores and that seems to be 
absent in B. cereus ATCC 10987.
5. METHODOLOGICAL RECOMMENDATIONS
Cereulide is a very hydrophobic compound, with very low solubility in H2O. The 
dilution  in  H2O caused  loss  antimicrobial  activity.  Therefore  dilution  in  H2O must  be 
avoided. Dissolution of cereulide in 100% DMSO showed to be a better approach. 
Although valinomycin is more easily dissolved in H2O, it  is also an hydrophobic 
compound which is more stable if dissolved in 100% DMSO. In 20% DMSO, the stability 
may decrease and it must be used within a short period of time.
The drop dilution assay must be preferred to the disk assay, since  the use of paper 
disks only allows the observation of a possible inhibition around the disk, while the direct 
spotting of the antibiotic solution on the bacterial cultures allows a better observation of 
that effect.
6. CONCLUSION AND FUTURE RESEARCH
The  present  study  shows  that,  comparatively  to  valinomycin,  cereulide  has 
antimicrobial activity against Gram positive bacteria. However, it is not clear if that is or 
not the main function of cereulide. 
Potassium ionophores  studied  were  found  to  be  more  effective  against  bacterial 
growth  in  presence  of  O2  and  at  alkaline  pH.  Since  pH  is  an  important  factor  for 
antimicrobial  effect  of cereulide,  the effect  of extracellular  pH on cereulide production 
could  be  analyzed  in  order  to  verify  if  there  is  a relation  between  the  production  of 
cereulide and its activity.
The loss  of  the membrane  potential  is  assumed as  the cause of  bacterial  growth 
inhibition by cereulide, but it was not proved yet. For this reason, the impact of cereulide 
on the membrane potential should be determined using fluorescent probes. 
Emetic strains exhibited low sensitive to valinomycin and resistance to cereulide. 
Curiously,  the  non-emetic  B.  cereus  ATCC 10987  and  B.  cereus  ATCC 14579 strains 
exhibited different sensitivity to valinomycin. To try to find out which system in B. cereus 
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ATCC 14579 confers some tolerance to valinomycin and that seems to be absent in  B. 
cereus  ATCC  10987  a  microarrray  platform  comparison  should  be  performed. 
Unfortunately, the results obtained do not allow the analysis of the effect of cereulide on 
the growth of B. cereus ATCC 14579. Thereby, the effect of cereulide on the growth of this 
strain should be evaluated.
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Appendix 1. Growth curves (OD600nm) of bacterial growth with and without
valinomycin under aerobic conditions
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Figure A-1. Aerobic growth of B. cereus F4810/72 in BHI broth, at a range of pH values (5.5 to 9.5) in
presence of 1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-2. Aerobic growth of B. cereus A529 in BHI broth, at a range of pH values (5.5 to 9.5) in presence
of 1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-3. Aerobic growth of B. cereus ATCC 14579 in BHI broth, at a range of pH values (5.5 to 9.5) in
presence of 1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-4. Aerobic growth of B. cereus ATCC 10987 in BHI broth, at a range of pH values (5.5 to 9.5) in
presence of 1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-5. Aerobic growth of B. subtilis in BHI broth, at a range of pH values (5.5 to 9.5) in presence of 1%
DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-6. Aerobic growth of L. monocytogenes in BHI broth, at a range of pH values (5.5 to 9.5) in
presence of 1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-7. Aerobic growth of L. innocua in BHI broth, at a range of pH values (5.5 to 9.5) in presence of
1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-8. Aerobic growth of S. aureus in BHI broth, at a range of pH values (5.5 to 9.5) in presence of 1%
DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-9. Aerobic growth of E. faecalis in BHI broth, at a range of pH values (5.5 to 9.5) in presence of
1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-10. Aerobic growth of E. coli in BHI broth, at a range of pH values (5.5 to 9.5) in presence of 1%
DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-11. Aerobic growth of S. thyphimurium in BHI broth, at a range of pH values (5.5 to 9.5) in
presence of 1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B). 
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Appendix  2.  Growth  curves  (OD600nm)  of  bacterial  growth  with  and  without
valinomycin under anaerobic conditions
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Figure A-12. Anaerobic growth of B. cereus F4810/72 in BHI broth, at a range of pH values (5.5 to 9.5) in
presence of 1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-13. Anaerobic growth of B. cereus A529 in BHI broth, at a range of pH values (5.5 to 9.5) in presence
of 1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-14. Anaerobic growth of B. cereus ATCC 14579 in BHI broth, at a range of pH values (5.5 to 9.5) in
presence of 1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-15. Anaerobic growth of B. cereus ATCC 10987 in BHI broth, at a range of pH values (5.5 to 9.5) in
presence of 1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-16. Anaerobic growth of B. subtilis in BHI broth, at a range of pH values (5.5 to 9.5) in presence of
1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-17. Anaerobic growth of L. monocytogenes in BHI broth, at a range of pH values (5.5 to 9.5) in
presence of 1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-18. Anaerobic growth of L. innocua in BHI broth, at a range of pH values (5.5 to 9.5) in presence of
1% DMS18 (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-19. Anaerobic growth of S. aureus in BHI broth, at a range of pH values (5.5 to 9.5) in presence of
1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-20. Anaerobic growth of E. faecalis in BHI broth, at a range of pH values (5.5 to 9.5) in presence of
1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-21. Anaerobic growth of E. coli in BHI broth, at a range of pH values (5.5 to 9.5) in presence of 1%
DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Figure A-22. Anaerobic growth of S. thyphimurium in BHI broth, at a range of pH values (5.5 to 9.5) in
presence of 1% DMSO (A) and in presence of valinomycin (9 µM) with 1% DMSO (B).
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Appendix  3.  Comparison  of  inhibition  induced  by  valinomycin  in  aerobic  and
anaerobic conditions
Figure A-23. Relative growth rate – RGR (A) and difference between the length of the lag phase of the growth
control and the growth with valinomycin – ∆lag (B) of B. cereus F4810/72 exposed to 9 µM of valinomycin
and 1 % DMSO in BHI broth at different pHs, at 30°C, under aerobic and anaerobic conditions. Red line
(RGR = 100 %) indicates no inhibition. Statistical significant difference between growth control and growth
test (*), p<0.05.
Figure A-24. Relative growth rate – RGR (A) and difference between the length of the lag phase of the growth
control and the growth with valinomycin – ∆lag (B) of B. cereus A529 exposed to 9 µM of valinomycin and 1
% DMSO in BHI broth at different pHs, at 30°C, under aerobic and anaerobic conditions. Red line (RGR =
100 %) indicates no inhibition. Statistical significant difference between growth control and growth test (*),
p<0.05.
Figure A-25. Relative growth rate – RGR (A) and difference between the length of the lag phase of the growth
control and the growth with valinomycin – ∆lag (B) of B. cereus ATCC 14579 exposed to 9 µM of
valinomycin and 1 % DMSO in BHI broth at different pHs, at 30°C, under aerobic and anaerobic conditions.
Red line (RGR = 100 %) indicates no inhibition. Statistical significant difference between growth control and
growth test (*), p<0.05.
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Figure A-26. Relative growth rate – RGR (A) and difference between the length of the lag phase of the growth
control and the growth with valinomycin – ∆lag (B) of B. cereus ATCC 10987 exposed to 9 µM of
valinomycin and 1 % DMSO in BHI broth at different pHs, at 30°C, under aerobic and anaerobic conditions.
Red line (RGR = 100 %) indicates no inhibition. Statistical significant difference between growth control and
growth test (*), p<0.05.
Figure A-27. Relative growth rate – RGR (A) and difference between the length of the lag phase of the growth
control and the growth with valinomycin – ∆lag (B) of B. subtilis exposed to 9 µM of valinomycin and 1 %
DMSO in BHI broth at different pHs, at 30°C, under aerobic and anaerobic conditions. Red line (RGR = 100
%) indicates no inhibition. Statistical significant difference between growth control and growth test (*),
p<0.05.
Figure A-28. Relative growth rate – RGR (A) and difference between the length of the lag phase of the growth
control and the growth with valinomycin – ∆lag (B) of L. monocytogenes exposed to 9 µM of valinomycin and
1 % DMSO in BHI broth at different pHs, at 30°C, under aerobic and anaerobic conditions. Red line (RGR =
100 %) indicates no inhibition. Statistical significant difference between growth control and growth test (*),
p<0.05.
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Figure A-29. Relative growth rate – RGR (A) and difference between the length of the lag phase of the growth
control and the growth with valinomycin – ∆lag (B) of L. innocua exposed to 9 µM of valinomycin and 1 %
DMSO in BHI broth at different pHs, at 30°C, under aerobic and anaerobic conditions. Red line (RGR = 100
%) indicates no inhibition. Statistical significant difference between growth control and growth test (*),
p<0.05.
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Appendix 4. Growth inhibition caused by a range of concentrations of valinomycin
Figure A-30. Relative growth rate – RGR (A) and difference between the length of the lag phase of the
growth control and the growth with valinomycin – ∆lag (B) of B. cereus F4810/72 exposed to a range of
valinomycin concentrations (0.09 to 44.99 µM) and 1 or 5 % of DMSO, in BHI broth at different pHs, at
30°C, with aeration. Red line (RGR = 100 %) indicates no inhibition. Statistical significant difference
between growth control and growth test (*), p<0.05.
Figure A-31. Relative growth rate – RGR (A) and difference between the length of the lag phase of the
growth control and the growth with valinomycin – ∆lag (B) of B. cereus A529 exposed to a range of
valinomycin concentrations (0.09 to 44.99 µM) and 1 or 5 % of DMSO, in BHI broth at different pHs, at
30°C, with aeration. Red line (RGR = 100 %) indicates no inhibition. Statistical significant difference
between growth control and growth test (*), p<0.05.
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Figure A-32. Relative growth rate – RGR (A) and difference between the length of the lag phase of the
growth control and the growth with valinomycin – ∆lag (B) of B. cereus ATCC 14579 exposed to a range of
valinomycin concentrations (0.09 to 44.99 µM) and 1 or 5 % of DMSO, in BHI broth at different pHs, at
30°C, with aeration. Red line (RGR = 100 %) indicates no inhibition. Statistical significant difference
between growth control and growth test (*), p<0.05.
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